ScholarIQanswers from OpenAlex & ORCID
Lin Xu
ResearcherPublications, citations & collaboration network
Lin Xu is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Lin Xu have?
ScholarIQindexed works
Lin Xu has 730 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Lin Xu have?
ScholarIQcitation count
Lin Xu has 27,345 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Lin Xu?
ScholarIQh-index
Lin Xu has an h-index of 74 in OpenAlex.
What is the i10-index of Lin Xu?
ScholarIQi10-index
Lin Xu has an i10-index of 360 in OpenAlex.
What is the ORCID of Lin Xu?
ScholarIQorcid
The ORCID for Lin Xu is on the source record.
What is the OpenAlex record for Lin Xu?
ScholarIQopenalex
The OpenAlex for Lin Xu is on the source record.
What are the most-cited papers on Lin Xu?
ScholarIQmost cited works
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
Wen‐Zhao Zhong, Qun Wang, Weimin Mao, Lin Xu, Lin Wu, Yi Shen, Yu Liu, Chun Chen, Ying Cheng, Lin Xu, Jun Wang, Fei Ke, Xiaofei Li, Jian Li, Cheng Huang, Zhidong Liu, Shun Xu, Ke‐Neng Chen, Shidong Xu, Lunxu Liu, Ping Yu, Buhai Wang, Haitao Ma, Hong‐Hong Yan, Xue‐Ning Yang, Qing Zhou, Yi‐Long Wu, Yi‐Long Wu, Qun Wang, Weimin Mao, Lin Wu, Yi Shen, Yu Liu, Chun Chen, Ying Cheng, Lin Xu, Jun Wang, Fei Ke, Xiaofei Li, Jian Li, Cheng Zhi Huang, Zhidong Liu, Shun Xu, Ke‐Neng Chen, Shidong Xu, Lunxu Liu, Ping Yu, Buhai Wang, Haitao Ma, Siyu Wang, Jian Hu, Wei Liu, Wěi Li, Jianhua Shi
A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese
Zhibin Hu, Chen Wu, Yongyong Shi, Huan Guo, Xueying Zhao, Zhihua Yin, Lei Yang, Juncheng Dai, Lingmin Hu, Wen Tan, Zhiqiang Li, Qifei Deng, Jiucun Wang, Wei Wu, Guangfu Jin, Yue Jiang, Dianke Yu, Guoquan Zhou, Hongyan Chen, Peng Guan, Yijiang Chen, Yongqian Shu, Lin Xu, Xiangyang Liu, Li Liu, Ping Xu, Baohui Han, Chunxue Bai, Yuxia Zhao, Haibo Zhang, Ying Yan, Hongxia Ma, Jiaping Chen, M. K. M. Chu, Feng Lu, Zhengdong Zhang, Feng Chen, Xinru Wang, Jin Li, Jiachun Lü, Baosen Zhou, Daru Lu, Tangchun Wu, Dongxin Lin, Hongbing Shen
Early versus delayed administration of norepinephrine in patients with septic shock
Xiaowu Bai, Wenkui Yu, Ji Wu, Zhiliang Lin, Shanjun Tan, Kaipeng Duan, Yi Dong, Lin Xu, Ning Li
Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer
Liyan Jiang, Jiaqi Huang, Brandon W. Higgs, Zhibin Hu, Zhan Xiao, Xin Yao, Sarah J. Conley, Haihong Zhong, Zheng Liu, Philip Z. Brohawn, Dong Shen, Song Wu, Xiaoxiao Ge, Yue Jiang, Yizhuo Zhao, Yuqing Lou, Chris Morehouse, Wei Zhu, Yinong Sebastian, Meggan Czapiga, Vaheh Oganesyan, Haihua Fu, Yanjie Niu, Wei Zhang, Katie Streicher, David A. Tice, Heng Zhao, Meng Zhu, Lin Xu, Ronald Herbst, Xinying Su, Yi Gu, Shyoung Li, Lihua Huang, Jianren Gu, Baohui Han, Bahija Jallal, Hongbing Shen, Yihong Yao
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial
Wen-Zhao Zhong, Qun Wang, Weimin Mao, Lin Xu, Lin Wu, Yucheng Wei, Yong-Yu Liu, Chun Chen, Ying Cheng, Rong Yin, Fan Yang, Shengxiang Ren, Xiaofei Li, Jian Li, Cheng Huang, Zhidong Liu, Shun Xu, Ke‐Neng Chen, Shidong Xu, Lunxu Liu, Ping Yu, Buhai Wang, Haitao Ma, Jin‐Ji Yang, Hong‐Hong Yan, Xue‐Ning Yang, Si‐Yang Liu, Qing Zhou, Yi‐Long Wu